Experts address COVID-19 vaccine myths, safety evidence, and how to frame the benefits of vaccination in pregnancy.
|Articles|July 12, 2018
- Vol. 64 No. 07
- Volume 64
- Issue 7
Maternal Mortality resources: Amniotic Embolism
Advertisement
A collection of standards, guidelines, tools and articles for the OB managing amniotic embolism. Plus: A recently published study from our Maternal Mortality Series Editor, Carolyn Zelop, MD, along with Stephanie Martin, DO, that discusses the specifics of dealing with maternal cardiac arrest that occurs during pregnancy.
Having trouble viewing?
Trouble viewing this PDF?
Once you access the file, position your mouse over the top middle for a toolbar:
Articles in this issue
over 8 years ago
Long-term maternal benefits of breastfeedingover 8 years ago
Oxytocin suspect in cases with poor outcomesover 8 years ago
ERAS: Improved outcomes post-cesareanover 8 years ago
Fertility banking – how secure is it?Advertisement
Related to this article
Experts look ahead to new maternal vaccines and how to counsel patients on receiving several in one pregnancy.
In September, the FDA accepted an extended duration sNDA for the IUD with a decision expected in Q2 2027.
Experts discuss common patient concerns about vaccination in pregnancy and strategies to improve uptake.
ACOG issued its most comprehensive menopause guidance, grading treatments for VMS, sleep, and mood symptoms.
Experts discuss how obstetric and pediatric clinicians can coordinate to protect newborns.
Experts review ACOG's 2026-27 guidance and the RSV window extension for pregnant and postpartum patients.
Soma Mandal, MD, is launching “Mind, Body, & the Pause: the Perimenopause and Beyond Series” on Contemporary OB/GYN, featuring specialists from across Hackensack Meridian Health.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
ACOG guideline expands menopause VMS, sleep, and mood recommendations
2
Countering COVID-19 vaccine myths in pregnancy
3
Organon reports interim phase 3 data for MIUDELLA IUD through 6 years
4
What ACOG's 2026-27 respiratory virus guidance means in practice
5